Keywords: آنتراسیکلین; anthracyclines; cardio-oncology; 3D echocardiography; GCS; global circumferential strain; GLS; global longitudinal strain; IQR; interquartile range; LVEF; left ventricular ejection fraction; STE; speckle-tracking echocardiography;
مقالات ISI آنتراسیکلین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتراسیکلین; Ionic gradient liposomes; Anthracyclines; Local anesthetics; pKa; Weak base; Entrapment; Controlled release; Drug delivery;
Keywords: آنتراسیکلین; Cancer therapy-mediated cardiotoxicity; Chemotherapy-induced cardiomyopathy; Anthracyclines; HER2-targeted therapies; Trastuzumab; Radiotherapy-induced cardiotoxicity; β-Blockers; Renin-angiotensin inhibitors;
Keywords: آنتراسیکلین; Chemotherapy; Antineoplastics; Anthracyclines; Taxanes; Molecular targeted therapies; Adverse effects; Heart failure; QTc prolongation; Tyrosine kinase inhibitors; Monoclonal antibodies; Cardio-oncology; Patient safety;
Keywords: آنتراسیکلین; Late effects; Anthracyclines; Cardiotoxicity; Ewing sarcoma; Echocardiography;
Keywords: آنتراسیکلین; Breast cancer; Heart disease; Radiotherapy; Anthracyclines;
Keywords: آنتراسیکلین; Heart failure; Right ventricular failure; Chemotherapy-induced cardiomyopathy; Cancer therapeutics-related cardiac dysfunction; Anthracyclines; Mechanical circulatory support devices; Heart transplant; Cardiac resynchronization therapy;
Keywords: آنتراسیکلین; Lymphoma; Chemotherapy; Anthracyclines; Liposomal doxorubicin; Acute decompensated heart failure; Cardio-oncology;
Keywords: آنتراسیکلین; Anthracyclines; Deacetylase inhibitors; Drug resistance; Proteasome activity; Proteasome inhibitors;
Keywords: آنتراسیکلین; Heart failure; Cancer; Cardiotoxicity; Cardioprotection; Anthracyclines; Trastuzumab; Cardio-oncology; Myocardial dysfunction;
Keywords: آنتراسیکلین; Cancer diagnosis; Heart failure; Cardiovascular toxicity; Anthracyclines; Fibrosis; Anthracyclinesibrosis; Tyrosine kinase inhibitors; PD-1;
Keywords: آنتراسیکلین; Alkylating agents; anthracyclines; antimetabolites; cancer; chemotherapy; cytotoxic; platinum compounds
Keywords: آنتراسیکلین; Anthracyclines; Echocardiography; Lymphoma survivors; Radiotherapy; Right ventricle; Auto-HCT; Autologous hematopoietic stem cell transplantation; FAC; Fractional area change; GLS; Global longitudinal strain; LS; Lymphoma survivor; LV; Left ventricular; R
Keywords: آنتراسیکلین; Anthracyclines; Daunorubicin; Doxorubicin; Cardiotoxicity; Cardiomyopathy; Tolerance; Screening; Prophylaxis; Assessment
Keywords: آنتراسیکلین; anthracyclines; autologous hematopoietic stem cell transplantation; cardiotoxicity; echocardiography; lymphoma survivors; radiation therapy; valvular dysfunctionACCT, anthracycline-containing chemotherapy; auto-HCT, autologous hematopoietic stem cell tran
Keywords: آنتراسیکلین; Heart failure; antineoplastic drugs-induced cardiotoxicity; anthracyclines; receptor tyrosine kinase
Keywords: آنتراسیکلین; Anthracyclines; Cardiotoxicity; Myocardial strain; Cardiovascular imaging agents/techniques; Echocardiography; AUC; Area under the curve; CMR; Cardiac magnetic resonance imaging; CTRCD; Cancer therapeutics-related cardiac dysfunction; EF; Ejection fract
Keywords: آنتراسیکلین; Anthracyclines; Cardiotoxicity; Prevention; ChemotherapyAntraciclinas; Cardiotoxicidade; Prevenção; Quimioterapia
Keywords: آنتراسیکلین; Intramolecular; Carbonyl-ene; Hydroaromatics; Anthracyclines;
Keywords: آنتراسیکلین; Liposome; Nanomedicine; Drug delivery; Anthracyclines; Chemotherapy;
Keywords: آنتراسیکلین; Anthracyclines; Solid tumors; Drug delivery systems; Transferrin;
Keywords: آنتراسیکلین; Anthracyclines; Cardiotoxicity; Cardioprotection; Dexrazoxane; Inorganic nitrate and nitrite;
Keywords: آنتراسیکلین; Non-Hodgkin's lymphoma; Anthracyclines; International prognosis index; AgeLinfoma no hodgkiniano; Antraciclinas; Índice pronóstico internacional; Edad
Keywords: آنتراسیکلین; Anthracyclines; Doxorubicin; Anticancer immunity; Immunomodulation; Chemoimmunotherapy;
Keywords: آنتراسیکلین; ANP; atrial natriuretic peptide; BNP; brain natriuretic peptide; Brca; breast cancer associated; BW; body weight; Col; collagenase; Con; control; CTGF; connective tissue growth factor; DAPI; 4â²,6-diamidino-2-phenylindole; Doxo; doxorubicin; Gpx1; glutat
Keywords: آنتراسیکلین; Cardiac toxicity; Chemotherapy; Anthracyclines; Troponin; Natriuretic peptides;
Keywords: آنتراسیکلین; Speckle tracking echocardiography; Cardiotoxicity; Chemotherapy; Trastuzumab; Anthracyclines;
Keywords: آنتراسیکلین; cardiotoxicity; anthracyclines; trastuzumab; oxidative stress
Keywords: آنتراسیکلین; Pediatric cardio-oncology; Long-term survivors; Cardioprotection; Late cardiotoxicity; Anthracyclines; Dexrazoxane;
Keywords: آنتراسیکلین; Anthracyclines; Dexrazoxane; Childhood cancer survivors; Cardiac late effects; Cardiotoxicity; Childhood cancer;
Keywords: آنتراسیکلین; Anthracyclines; Cancer survivorship; Cardioprotection; Cardiotoxicity; Dexrazoxane; Secondary malignancies;
Keywords: آنتراسیکلین; Anthracyclines; Cardiotoxicity; Heart failure; Reactive oxygen species; Oxidative stress
Keywords: آنتراسیکلین; Anthracyclines; Her2; Metastatic breast cancer; Overall survival; Palliative chemotherapy;
Keywords: آنتراسیکلین; Anthracyclines; Electron beam irradiation; Multidrug resistance; Apoptosis; Acute lymphoblastic leukemiaDAU, daunorubicin; DOX, doxorubicin; EPI, epirubicin; IR, irradiated; NIR, non-irradiated; MDR, multidrug resistance
TransArterial ChemoEmbolization (TACE) with platinum versus anthracyclines for hepatocellular carcinoma: A meta-analysis
Keywords: آنتراسیکلین; HCC; TACE; Platinum; Anthracyclines; Meta-analysis;
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
Keywords: آنتراسیکلین; Anthracyclines; Troponin; Cancer chemotherapy; Clinical trial; Cardiotoxicity; Enalapril;
Left Ventricular Dysfunction in Cancer Treatment
Keywords: آنتراسیکلین; anthracyclines; cancer treatment; cardiotoxicity; HER2-targeted therapy; LV dysfunction; ACCF; American College of Cardiology Foundation; AHA; American Heart Association; ASCO; American Society of Clinical Oncology; ASE; American Society of Echocardiograp
Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment
Keywords: آنتراسیکلین; AKR; aldo-keto reductase; CDK; cyclin-dependent kinase; CI; combination index; Dau; daunorubicin; Dau-ol; daunorubicinol; DOX; doxorubicin; DMSO; dimethyl sulfoxide; Fa; fraction affected; HCT116-AKR1C3; cells transfected with pCI_AKR1C3; HCT116-EV; cells
YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy
Keywords: آنتراسیکلین; Sarcoma; Endometrial stromal sarcoma; Anthracyclines; Uterine mesenchymal neoplasms;
Effective use of levosimendan in anthracycline-induced cardiomyopathy: A case report
Keywords: آنتراسیکلین; Anthracyclines; Doxorubicin; Cardiomyopathy; Heart failure; Cardiotoxicity; Levosimendan; A; transmitral peak A-wave velocity; E; transmitral peak E-wave velocity; Ea; early diastolic lateral mitral annulus velocity; IVC; Inferior vena cava diameter; LVED
Carrefour des spécialitésFacteurs de risque et surveillance à long terme des complications cardiaques après traitement pour un cancer pendant l'enfanceTreatment-related cardiotoxicity in childhood cancer survivors: Risk factors and follow-up
Keywords: آنتراسیکلین; Cardiomyopathies; Coronaropathie; Anthracyclines; Irradiation; Cancers de l'enfant; Cardiomyopathy; Coronary lesions; Anthracycline; Radiotherapy; Neoplasia of the young;
A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo
Keywords: آنتراسیکلین; Antibodies; Protein engineering; Vascular targeting; Antibody-drug conjugates; Anthracyclines;
Daunorubicin and doxorubicin molecular interplay with 2D membrane models
Keywords: آنتراسیکلین; BAM; Brewster angle microscopy; Chol; Cholesterol; DPPC; dipalmitoylphosphatidylcholine; IR; infra-red; LC; liquid-condensed; LE; liquid-expanded; LO; liquid-ordered; SM; sphingomyelin; PM-IRRAS; Polarization modulation infrared reflection-absorption spec
An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity
Keywords: آنتراسیکلین; alpha adrenergic receptors; anthracyclines; cardioprotection; catecholamines; heart failure; α1-AR; alpha-1 adrenergic receptor; AKO; alpha-1A adrenergic receptor knockout; ATP; adenosine triphosphate; BP; blood pressure; DOX; doxorubicin; EC50; half-max
Cardio-oncology Related to Heart Failure
Keywords: آنتراسیکلین; Childhood cancer survivors; Anthracyclines; Cardiac dysfunction; Cardiotoxicity;
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer
Keywords: آنتراسیکلین; Adjuvant chemotherapy; Anthracyclines; Circulating tumor cells; HER2-negative early breast cancer;
Speckle-Tracking Echocardiography to Detect Cardiac Toxicity in Children Who Received Anthracyclines During Pregnancy
Keywords: آنتراسیکلین; Anthracyclines; Cardiac toxicity; Echocardiogram; Hematologic malignancies; Hodgking lymphoma and pregnancy; Lymphoma and pregnancy;
Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study
Keywords: آنتراسیکلین; Advanced breast cancer; Anthracyclines; Pegylated liposomal doxorubicin (PLD); Phase II Trial;
The relationship between plasma hyaluronan levels and anthracycline-related cardiotoxicity in breast cancer patients
Keywords: آنتراسیکلین; Anthracyclines; Hyaluronan; Cardiotoxicity;
Spectroscopic studies of anthracyclines: Structural characterization and in vitro tracking
Keywords: آنتراسیکلین; Anthracyclines; UV–Vis spectroscopy; FT-IR spectroscopy; Raman spectroscopy; Doxorubicin in vitro; Drug-cell interactions